References
- Gonzalez JF, Alcántara AR, Doadrio AL, et al. Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches. Expert Opin Drug Discov. 2019;1–13.
- Chen R, Chan P, Chu H, et al. Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: a meta- analysis. PLoS One. 2017;12:e0183586.
- Le Pichon CE, Meilandt WJ, Dominguez S, et al. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med. 2017;9:pii: eaag0394.
- Patel S, Harris SF, Gibbons P. Scaffold-hopping and structure-based discovery of potent, selective, and brain penetrant N-(1H-Pyrazol-3-yl) pyridin-2-amine inhibitors of Dual Leucine zipper kinase (DLK, MAP3K12). J Med Chem. 2015;58:8182–8199.
- Hayes MJ, Stein M, Weiser J. Accurate calculations of ligand binding free energies: chiral separation with enantioselective receptors. J Phys Chem A. 2004;108:3572–3580.
- Shruthy VS, Yusuf S. In silico design, docking, synthesis and evaluation of thiazole schiff bases. Int J Pharm Pharm Sci. 2014;6:271–275.
- Daisy P, Vijayalakshmi P, Selvaraj C, et al. Targeting multidrug resistant Mycobacterium tuberculosis HtrA2 with identical chemical entities of fluoroquinolones. Indian J Pharm Sci. 2012;4:217–222.
- Sitemap, version 2.4; New York, NY: Schrödinger, LLC; 2008.
- Vijayalakshmi P, Nisha J, Rajalakshmi M. Virtual Screening of potential inhibitor against FtsZ protein from Staphylococcus aureus. Interdiscip Sci Comput Life Sci. 2014;6:331–339.
- Halgren TA. Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model. 2009;49:377–389.
- Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring: method and assessment of docking accuracy. J Med Chem. 2004;47:1739–1749.
- Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49:6177–6196.
- Sengupta D, Verma D, Naik PK. Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: Screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties. J Biosci. 2007;32:1307–1316.
- Salam NK, Nuti R, Sherman W. Novel method for generating structure-based pharmacophores using energetic analysis. J Chem Inf Model. 2009;49:2356–2368.
- Vijayalakshmi P, Selvaraj C, Shafreen RM, et al. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus. J Mol Recognit. 2014;27:429–437.
- Loving K, Salam NK, Sherman W. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation. J Comput Aided Mol Des. 2009;23:541–554.
- Mobley DL, Dill KA. Binding of small-molecule ligands to proteins: “what you see” is not always “what you get”. Structure. 2009;17:489–498.
- Lyne PD, Lamb ML, Saeh JC. Accurate pre-diction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem. 2006;4:4805–4808.
- Das D, Koh Y, Tojo Y, et al. Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model. J Chem Inf Model. 2009;49:2851–2862.
- Jorgensen WL, Duffy EM. Prediction of drug solubility from structure. Adv Drug Deliv Rev. 2002;54:355–366.
- QikProp (2010) Version 3.3, New York: Schrodinger, LLC.
- Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.
- Galeazzi R. Molecular dynamics as a tool in rational drug design: current status and some major applications. Curr Comput Aided Durg Des. 2009;4:225–240.
- Maragakis P, Lindorff-Larsen K, Eastwood MP, et al. Microsecond molecular dynamics simula- tion shows elect of slow loop dynamics on backbone amide order parameters of proteins. J Phys Chem B. 2008;112:6155–6158.
- Jorgensen AM, Topiol S. Driving forces for ligand migration in the leucine transporter. Chem Biol Drug Des. 2008;72:265–272.
- Kansal N, Silakari O, Ravikumar M. Three-dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors. Eur J Med Chem. 2010;45:393–404.